APA (7th ed.) Citation

SF, V., S, O., J, B., JY, K., OS, K., C, W., . . . BK, S. (2025). Docking 14 million virtual isoquinuclidines against the mu and kappa opioid receptors reveals dual antagonists-inverse agonists with reduced withdrawal effects. BioRxiv : the preprint server for biology. https://doi.org/10.1101/2025.01.09.632033

Chicago Style (17th ed.) Citation

SF, Vigneron, et al. "Docking 14 Million Virtual Isoquinuclidines Against the Mu and Kappa Opioid Receptors Reveals Dual Antagonists-inverse Agonists with Reduced Withdrawal Effects." BioRxiv : The Preprint Server for Biology 2025. https://doi.org/10.1101/2025.01.09.632033.

MLA (9th ed.) Citation

SF, Vigneron, et al. "Docking 14 Million Virtual Isoquinuclidines Against the Mu and Kappa Opioid Receptors Reveals Dual Antagonists-inverse Agonists with Reduced Withdrawal Effects." BioRxiv : The Preprint Server for Biology, 2025, https://doi.org/10.1101/2025.01.09.632033.